Quantzig | Clinical Data Analytics Accelerates Drug R&D for a Swiss BioPharma and Life Sciences Group - Submit RFP for In-depth Engagement Insights

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Jan 14, 2021 11:15 am
LONDON -- 

Global biopharmaceutical and life sciences companies are innovating and digitally transforming clinical trials with analytics. From getting trials up and running to streamlining clinical trial designs to deliver new drugs and vaccines faster, clinical data analytics has impacted every aspect of drug discovery and development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005387/en/

Accelerating Drug Research & Development for a BioPharma and Life Sciences Company (Graphic: Business Wire)

Accelerating Drug Research & Development for a BioPharma and Life Sciences Company (Graphic: Business Wire)

To support the modern clinical trial needs, Quantzig unveiled its new pharma and life science analytics framework, which helps biopharma and life sciences companies and researchers predict drug behavior, improve the selection criteria for clinical trials, and drive data-driven decisions for a higher success rate and faster time-to-market. Learn more about our industry-leading, innovative analytics solutions for the pharma and life sciences industry: https://bit.ly/2XEb8qt

Clinical data analytics is at an inflection point with accelerated drug development and vaccines for COVID-19, coupled with a move toward decentralized, hybrid clinical trials,” said an analytics expert at Quantzig.

Quantzig’s latest clinical data analytics success story sheds light on the importance of data and analytics in drug development.

Quantzig is now offering a limited-period free demonstration of its proprietary analytics framework for all pharma and life sciences companies. Get in touch before it's too late: https://bit.ly/3oIgFbp

A leading Swiss life sciences company selected Quantzig as a long-term strategic analytics partner to support its clinical research objective. Quantzig helped the client deliver personalized health care solutions by streamlining drug discovery and integrating pharmaceutical products with diagnostics and patient data obtained from disparate sources.

Quantzig adopted a comprehensive approach backed with research insights, analytical views, and evidence-based solutions that helped the client tackle their challenges.

> The first phase of the engagement focused on analyzing the market and the challenges faced by the client. To do so, Quantzig leveraged research insights from its in-house market research team and analyzed the current business scenario to gain a better hold of challenges and new opportunities that can impact the client’s business.

> The second phase focused on developing analytics-based approaches to streamline the client’s data management and drug development process. With several data sets in silos, the client faced challenges in integrating and analyzing them during trial design and analysis.

> The final phase of this engagement revolved around standardizing clinical trial processes, storing and duplicating data, and reducing the time and resources spent developing new drugs and getting to the drug market.

Request a FREE proposal to understand the potential benefits of analytics in drug development.

The success story serves as a classic example of Quantzig’s advanced clinical data analytics capabilities that span different areas of drug discovery, drug development, and patient analysis. However, the crux of it stresses the need for a streamlined process that can offer in-depth data-driven insights to help pharma and life sciences firms better understand market needs and act in real-time to save millions.

Follow us on LinkedIn and Twitter to keep abreast of the upcoming trends in pharma and life sciences.

About Quantzig

Quantzig is the world's foremost full-service advanced analytics and business intelligence solution provider, turning clients' complex, unstructured data into intelligent, actionable insights that enable them to solve complex business problems and inspire innovation, change, and growth.

Over the past 16 years, our insights have helped over 120 clients spanning across industries and sectors like Pharmaceutical and Life Sciences, Retail and CPG, Food and Beverage, and more. We have successfully delivered 1500 in-depth solutions in areas like Marketing Analytics, Customer Analytics, Supply Chain Analytics, and more. For more information on our engagement policies and pricing plans, visit https://www.quantzig.com/request-for-proposal.

Press Contact
Quantzig
Eva Sharma
Marketing Manager
US: +1 630 538 7144
UK: +44 208 629 1455
https://www.quantzig.com/contact-us

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).